Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L Gargas

Showing results (21-30 of 62) with videos related to

Pageof 7
Sort By:
Toxicology and Applied Pharmacology|July 1, 1991
PB-PK derived metabolic constants, hepatotoxicity, and lethality of BrCCl3 in rats pretreated with chlordecone, phenobarbital, or mirexK N Thakore, M L Gargas, M E Andersen, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|April 1, 1995
Development of a mechanism-based dosimetry model for 2,4,4-trimethyl-2-pentanol-induced alpha 2u-globulin nephropathy in male Fischer 344 ratsS J Borghoff, M L Gargas, M E Andersen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1994
Urinary excretion of chromium by humans following ingestion of chromium picolinate. Implications for biomonitoringM L Gargas, R L Norton, D J Paustenbach, et al.
Regulatory Toxicology and Pharmacology : RTP|November 19, 2003
Assessing the dose-dependency of allometric scaling performance using physiologically based pharmacokinetic modelingC R Kirman, L M Sweeney, M E Meek, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|January 27, 2009
Acrylamide: Consideration of species differences and nonlinear processes in estimating risk and safety for human ingestionM L Gargas, C R Kirman, L M Sweeney, et al.
Toxicology and Applied Pharmacology|February 1, 1996
In vivo and in vitro studies of perchloroethylene metabolism for physiologically based pharmacokinetic modeling in rats, mice, and humansR H Reitz, M L Gargas, A L Mendrala, et al.
Neurotoxicology and Teratology|March 1, 1995
Development of a physiologically based pharmacokinetic model for 2,4-dichlorophenoxyacetic acid dosimetry in discrete areas of the rabbit brainC S Kim, W Slikker, Z Binienda, et al.
Toxicology and Applied Pharmacology|March 15, 1980
The significance of multiple detoxification pathways for reactive metabolites in the toxicity of 1,1-dichloroethyleneM E Andersen, O E Thomas, M L Gargas, et al.
Toxicology and Applied Pharmacology|February 1, 1987
Physiologically based pharmacokinetics and the risk assessment process for methylene chlorideM E Andersen, H J Clewell, M L Gargas, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|February 1, 1990
Dermal absorption of organic chemical vapors in rats and humansJ N McDougal, G W Jepson, H J Clewell, et al.
Pageof 7

Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
Toxicology and Applied Pharmacology|July 1, 1991
PB-PK derived metabolic constants, hepatotoxicity, and lethality of BrCCl3 in rats pretreated with chlordecone, phenobarbital, or mirexK N Thakore, M L Gargas, M E Andersen, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|April 1, 1995
Development of a mechanism-based dosimetry model for 2,4,4-trimethyl-2-pentanol-induced alpha 2u-globulin nephropathy in male Fischer 344 ratsS J Borghoff, M L Gargas, M E Andersen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1994
Urinary excretion of chromium by humans following ingestion of chromium picolinate. Implications for biomonitoringM L Gargas, R L Norton, D J Paustenbach, et al.
Regulatory Toxicology and Pharmacology : RTP|November 19, 2003
Assessing the dose-dependency of allometric scaling performance using physiologically based pharmacokinetic modelingC R Kirman, L M Sweeney, M E Meek, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|January 27, 2009
Acrylamide: Consideration of species differences and nonlinear processes in estimating risk and safety for human ingestionM L Gargas, C R Kirman, L M Sweeney, et al.
Toxicology and Applied Pharmacology|February 1, 1996
In vivo and in vitro studies of perchloroethylene metabolism for physiologically based pharmacokinetic modeling in rats, mice, and humansR H Reitz, M L Gargas, A L Mendrala, et al.
Neurotoxicology and Teratology|March 1, 1995
Development of a physiologically based pharmacokinetic model for 2,4-dichlorophenoxyacetic acid dosimetry in discrete areas of the rabbit brainC S Kim, W Slikker, Z Binienda, et al.
Toxicology and Applied Pharmacology|March 15, 1980
The significance of multiple detoxification pathways for reactive metabolites in the toxicity of 1,1-dichloroethyleneM E Andersen, O E Thomas, M L Gargas, et al.
Toxicology and Applied Pharmacology|February 1, 1987
Physiologically based pharmacokinetics and the risk assessment process for methylene chlorideM E Andersen, H J Clewell, M L Gargas, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|February 1, 1990
Dermal absorption of organic chemical vapors in rats and humansJ N McDougal, G W Jepson, H J Clewell, et al.
Pageof 7